Surgical treatment and prognostic factors for obstructing left colorectal cancer
2012-08-15ZhangMaoshen
/Zhang Maoshen
(张茂申,Dept Gen Surg,Affil Hosp Med Col,Qingdao Univ,Qingdao 266003)…∥Chin J Gastrointest Surg.-2011,15(8).-620~622
ObjectiveTo investigate the outcomes of surgical treatment and the prognostic factors of long-term survival for obstructing left colorectal cancer.MethodsClinicopathological and follow-up data of 93 patients with obstructing left colorectal cancer undergoing surgical treatment from January 2001 to December 2006 in the Affiliated Hospital of Medical College of Qingdao University were analyzed retrospectively.ResultsThere were 53 males and 40 females.The median age was 61 years old.Fifty-one patients had concurrent medical condition.Radical resection was performed in 67 patients,including one-stage resection(n=21),Hartmann procedure(n=35),and Miles procedure(n=11).Surgery was palliative in 26 patients,including diverting stoma(n=14),bypass surgery(n=7),and palliative resection(n=5).All the93 patients were followed up.The 1- ,3- ,and 5-year survival rates were 94%,59%,and 38%,respectively.Univariate and multivariate analyses showed that radical resection,TNM staging,and preoperative level of carcinoembryonic antigen were independent prognostic factors(all P <0.05).ConclusionRadical resection,TNM stage,and preoperative CEA level are prognostic factors of obstructing left colorectal cancer.Early diagnosis,radical resection,aad selection of appropriate surgical procedure are helpful to prolong survival time of patients with obstructing left colorectal cancer.8 refs,1 fig,2 tabs.
杂志排行
外科研究与新技术的其它文章
- Value of diffusion-weighted MR imaging and dynamic-contrast enhanced MRI in the diagnosis of breast cancer
- Meta-analysis of the efficacy between gemcitabine-alone and gemcitabine-based chemotherapy applied to advanced pancreatic cancer
- Effect of decompression in different time on hemodynamics and oxygen metabolism of porcine model with severe acute pancreatitis combined intraabdominal hypertension
- Postoperative use of Sorafenib in liver transplantation patients of hepatocellular carcinoma beyond Milan criteria
- Combined liver-kidney transplantation and orthotopic liver transplantation in the treatment of severe hepatitis B
- HO-1 up-regulation decreases liver ischemia/reperfusion injury by inhibiting mast cells degranulation
